Genelife has given a fine start with its projects. Currently we are selecting five sites for Ulcerative Colitis study and twenty sites for Psoriasis study. The site selection is the initial and very crucial part of successful clinical research conduction. During the site selection visit, the site is identified and observed with the infrastructure and number of patients visited at the site along with the technical discussions of the study with the principal investigator.
The very first stage is to select the city for the study. According to the prevalence of the disease and the type of the study for Ulcerative Colitis, we selected Western Maharashtra, Eastern Uttar Pradesh, Punjab, etc. and for Psoriasis study, we have selected cities in Western Maharashtra, Central Madhya Pradesh, Eastern Uttar Pradesh, and some parts of Andhra Pradesh and in the Northern part of India. The experience gained during the site selection was priceless. The doctors’ approach towards our project was appreciable. We conducted the site selection visits in Western Maharashtra, Central Madhya Pradesh, Eastern Uttar Pradesh and Andhra Pradesh. We faced many problems during the process. While selecting the site, we looked for facilities available at the site, patient recruitment rate, and compliance of ICH-GCP guidelines. We also considered important suggestions from investigators related to protocol of the study, exclusion and inclusion criteria for recruiting the patients for the study. After the few site selections, we learned that along with the experience one becomes perfect in the field. We are looking forward for the site selection in Western India in next week and we would like to take all this experience for our future projects.
Ujwala Nikambe
CRA
Genelife Clinical Research
The very first stage is to select the city for the study. According to the prevalence of the disease and the type of the study for Ulcerative Colitis, we selected Western Maharashtra, Eastern Uttar Pradesh, Punjab, etc. and for Psoriasis study, we have selected cities in Western Maharashtra, Central Madhya Pradesh, Eastern Uttar Pradesh, and some parts of Andhra Pradesh and in the Northern part of India. The experience gained during the site selection was priceless. The doctors’ approach towards our project was appreciable. We conducted the site selection visits in Western Maharashtra, Central Madhya Pradesh, Eastern Uttar Pradesh and Andhra Pradesh. We faced many problems during the process. While selecting the site, we looked for facilities available at the site, patient recruitment rate, and compliance of ICH-GCP guidelines. We also considered important suggestions from investigators related to protocol of the study, exclusion and inclusion criteria for recruiting the patients for the study. After the few site selections, we learned that along with the experience one becomes perfect in the field. We are looking forward for the site selection in Western India in next week and we would like to take all this experience for our future projects.
CRA
Genelife Clinical Research
No comments:
Post a Comment